|
| 37782284 | Personal Stories From a World Turned Upside Down: Introducing the Voices of ID Collection. | Clin Infect Dis | 2024 |
| 36525259 | Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited. | | 2023 |
| 36111436 | Reply to Authors. | Clin Infect Dis | 2023 |
| 35986628 | Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019. | Clin Infect Dis | 2023 |
| 37947105 | Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy. | | 2023 |
| 37601728 | Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers. | | 2023 |
| 37792610 | Breaking Up Is Hard to Do - More Heartbreak from Corporate Decisions in Medicine. | | 2023 |
| 36718982 | Call to Action: Prioritizing the Use of Inclusive, Nonstigmatizing Language in Scientific Communications. | Clin Infect Dis | 2023 |
| 37200995 | Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials. | EClinicalMedicine | 2023 |
| 37387690 | Oral Nirmatrelvir and Ritonavir for Coronavirus Disease 2019 in Vaccinated, Nonhospitalized Adults Aged 18-50 Years. | Clin Infect Dis | 2023 |
| 37368931 | Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function. | J Acquir Immune Defic Syndr | 2023 |
| 37167996 | Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial. | Lancet HIV | 2023 |
| 36454551 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel. | JAMA | 2023 |
| 35111871 | Sustained HIV Viral Suppression With Dolutegravir, Tenofovir, and Emtricitabine as Initial Therapy Despite High-Level Transmitted Multiclass Resistance. | Open Forum Infectious Diseases | 2022 |
| 36309038 | Two-drug regimens for HIV treatment. | Lancet HIV | 2022 |
| 36243540 | Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week. | J Am Coll Cardiol | 2022 |
| 36008928 | Never Once Have I Ever Been Bored-Exciting Times Ahead for Clinical Infectious Diseases. | Clinical Infectious Diseases | 2022 |
| 35873288 | IgM Positivity for Both EBV and CMV: A Clinical Conundrum. | Open Forum Infectious Diseases | 2022 |
| 35466963 | High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I. | AIDS | 2022 |
| 34596223 | Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort. | Clin Infect Dis | 2022 |
| 34656209 | Reassessing oral lead-in for injectable long-acting HIV therapy. | Lancet HIV,The | 2021 |
| 33683930 | Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. | Ann Intern Med | 2021 |
| 33564779 | Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. | medRxiv | 2021 |
| 33987636 | Weight Change Following Antiretroviral Therapy Switch in People With Viral Suppression: Pooled Data from Randomized Clinical Trials. | Clinical Infectious Diseases | 2021 |
| 33651088 | Antiretroviral Drug Recommendations for HIV Treatment and Prevention-Reply. | JAMA | 2021 |
| 33336698 | Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority | Clinical Infectious Diseases | 2021 |
| 32905581 | Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019. | Clin Infect Dis | 2021 |
| 32668455 | Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus. | Clinical Infectious Diseases | 2021 |
| 32941052 | Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. | Annals of Internal Medicine | 2021 |
| 33418021 | Gender disparities in coronavirus disease 2019 clinical trial leadership. | Clinical Microbiology and Infection | 2021 |
| 34984212 | Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States. | Open Forum Infect Dis | 2021 |
| 31055599 | Clinical Impact and Cost-effectiveness of Genotype Testing at Human Immunodeficiency Virus Diagnosis in the United States. | Clin Infect Dis | 2020 |
| 31914799 | Prior Case of Resistance on Dolutegravir Plus Lamivudine Dual Therapy. | AIDS Research and Human Retroviruses | 2020 |
| 31740348 | Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial. | Lancet HIV,The | 2020 |
| 32415086 | Immune-profiling of ZIKV-infected patients identifies a distinct function of plasmacytoid dendritic cells for immune cross-regulation. | Nature Communications | 2020 |
| 32053682 | Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV. | PLoS One | 2020 |
| 31990705 | Antiretroviral therapy in older people with HIV. | | 2020 |
| 31929403 | Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States. | J Acquir Immune Defic Syndr | 2020 |
| 31606734 | Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials. | Clinical Infectious Diseases | 2020 |
| 32496516 | Maintenance of Viral Suppression in Human Immunodeficiency Virus Controllers Despite Waning T-Cell Responses During Antiretroviral Therapy. | J Infect Dis | 2020 |
| 33316192 | Web Exclusive. Annals for Hospitalists Inpatient Notes - Remdesivir-Making Sense of Emerging Evidence. | Annals of Internal Medicine | 2020 |
| 33094118 | Omadacycline for the Treatment of Disease: A Case Series. | Open Forum Infectious Diseases | 2020 |
| 32645158 | Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. | J Infect Dis | 2020 |
| 32587877 | Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases. | Open Forum Infectious Diseases | 2020 |
| 32504574 | Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials. | Lancet HIV | 2020 |
| 32558484 | Challenges of "Return to Work" in an Ongoing Pandemic. | New England Journal of Medicine | 2020 |
| 33052386 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. | JAMA | 2020 |
| 31131858 | Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers. | Clin Infect Dis | 2020 |
| 31121013 | Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety Analysis. | Clinical Infectious Diseases | 2020 |
| 30707104 | Middle-Aged Men With HIV Have Diminished Accelerometry-Based Activity Profiles Despite Similar Lab-Measured Gait Speed: Pilot Study. | JMIR mHealth and uHealth | 2019 |